Skip to main content
Clinical Trials/IRCT20210725051977N1
IRCT20210725051977N1CompletedPhase 2

Evaluation of the efficacy and safety of pregabalin and carbamazepine in patients with postherpetic neuralgia

Islamic Azad University0 sites40 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • Age older than 18
  • History of postherpetic neuralgia for at least 1 month

Exclusion Criteria

  • History of Allergy to carbamazepine or pregabaline
  • History of kidney or liver disease

Investigators

Similar Trials